The Food and Drug Administration (FDA) this week said it did not approve a two-minute coronavirus blood test that a company touted as receiving government approval.

The company, called BodySphere, made waves Tuesday when it announced it had received FDA approval for a blood test that could detect coronavirus in as little as two minutes, far faster than available tests that can take days.

But the FDA told CNN on Tuesday that it had not approved any of those types of blood tests, known as serology tests.

ADVERTISEMENT

"No serology tests have received an authorization to test for coronavirus," agency spokesman Michael Felderbaum told the cable news network.

A spokeswoman for the company, D'Anne Mica, said a day later that "there was a misunderstanding" and acknowledged that the FDA had not approved the test.

The company's CEO, Charlton Liu, also told CNN that the company "mistakenly believed" they had received approval "in the rush" to deliver the test.

Mica did not immediately respond to a request for comment from The Hill.

In Tuesday’s press release, the company called the test "a game changer."

The FDA, however, has approved a serology test.

An FDA official told The Hill on Thursday that the test from a company called Cellex "is the first serology test to date to receive authorization to test for the presence of coronavirus antibodies."

Updated at 7:42 p.m.